Clinical Trials at SCRI Oncology Partners

As of August 2026, 141 paid clinical trials are recruiting at SCRI Oncology Partners, located at SCRI Oncology Partners, 335 24th Ave N #200, Nashville, TN 37203, phone (615) 329-7640 in Nashville, Tennessee. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

View the full facility profile →

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

Filter results
Filter results
Recruitment status
Phase
Sex
Age

142 clinical trials at SCRI Oncology Partners

·Clear filters·
Get a weekly email when new trials open in Nashville, TN.

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

for Extensive-Stage Small Cell Lung Cancer
Drug: Atezolizumab
Sites in Nashville +17 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT06646276·Phase 3·Recruiting·Listed Oct 2024
Apply to this trial

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for Non-Small Cell Lung Cancer
Drug: Osimertinib
Sites in Nashville, Knoxville +13 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07155187·Phase 2, Phase 3·Recruiting·Listed Sep 2025
Apply to this trial